Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2004;109:634-640
doi: 10.1161/01.CIR.0000112572.57794.22
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmes, D. R.
Right arrow Articles by Kuntz, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmes, D. R., Jr
Right arrow Articles by Kuntz, R. E.
Related Collections
Right arrow Catheter-based coronary interventions: stents

(Circulation. 2004;109:634-640.)
© 2004 American Heart Association, Inc.

Clinical Investigation and Reports

Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial

A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis

David R. Holmes, Jr, MD; Martin B. Leon, MD; Jeffrey W. Moses, MD; Jeffrey J. Popma, MD; Donald Cutlip, MD; Peter J. Fitzgerald, MD, PhD; Charles Brown, MD; Tim Fischell, MD; Shing Chiu Wong, MD; Mark Midei, MD; David Snead, PhD; Richard E. Kuntz, MD, MSc

From Saint Mary’s Hospital (D.R.H.), Rochester, Minn; Lenox Hill Hospital, New York, NY (M.B.L., J.W.M.); Brigham and Women’s Hospital (J.J.P., R.E.K., D.C.), Boston, Mass; Stanford University Medical Center (P.J.F.), Stanford, Calif; Piedmont Hospital (C.B.), Atlanta, Ga; Borgess Medical Center (T.F.), Kalamazoo, Mich; Cornell University New York Presbyterian Hospital (S.C.W.), New York, NY; Saint Joseph’s Hospital (M.M.), Baltimore, Md; and Cordis (D.S.), Warren, NJ.

Reprint requests to David R. Holmes, Jr, MD, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail dholmes{at}mayo.edu

Received August 14, 2003; revision received October 31, 2003; accepted October 31, 2003.

Background— This study evaluated a large group of patients enrolled in a double-blind randomized trial of the sirolimus-eluting stent to document whether the initial clinical improvement seen in previous smaller series is maintained out to 12 months and to study the potential treatment effect in patient subsets known to be at increased risk of restenosis.

Methods and Results— A total of 1058 patients with de novo native coronary stenosis undergoing clinically indicated percutaneous coronary intervention were randomly assigned to sirolimus-eluting stent (533) or control bare stent (525). Procedural success and in-hospital outcomes were excellent and did not differ between the 2 groups. At 9 months, clinical restenosis, defined as target-lesion revascularization, was 4.1% in the sirolimus limb versus 16.6% in the control limb (P<0.001). At 12 months, the absolute difference in target-lesion revascularization continued to increase and was 4.9% versus 20% (P<0.001). There were no differences in death or myocardial infarction rates. In high-risk patient subsets, defined by vessel size, lesion length, and presence of diabetes mellitus, there was a 70% to 80% reduction in clinical restenosis at 1 year.

Conclusions— Placement of the sirolimus-eluting stent results in continued clinical improvement at 1 year after initial implantation, with significant reduction in clinical restenosis as defined by target-lesion revascularization. Between 9 and 12 months, the absolute reduction of clinical restenosis continues to increase. Even in high-risk subsets of patients, there is a 70% to 80% relative reduction in clinical restenosis at 12 months with this drug-eluting stent.


Key Words: stents • sirolimus • restenosis • coronary disease




This article has been cited by other articles:


Home page
 CJASNHome page
H. Ishii, Y. Kumada, T. Toriyama, T. Aoyama, H. Takahashi, S. Yamada, Y. Yasuda, Y. Yuzawa, S. Maruyama, S. Matsuo, et al.
Cilostazol Improves Long-Term Patency after Percutaneous Transluminal Angioplasty in Hemodialysis Patients with Peripheral Artery Disease
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1034 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. Mahmud, G. Bromberg-Marin, V. Palakodeti, L. Ang, D. Creanga, and A. N. DeMaria
Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2385 - 2395.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. W. Groeneveld, M. A. Matta, A. P. Greenhut, and F. Yang
Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2017 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Cyrus, H. Zhang, J. S. Allen, T. A. Williams, G. Hu, S. D. Caruthers, S. A. Wickline, and G. M. Lanza
Intramural Delivery of Rapamycin With {alpha}v{beta}3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 820 - 826.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. L. Hannan, M. Racz, D. R. Holmes, G. Walford, S. Sharma, S. Katz, R. H. Jones, and S. B. King III
Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents
Circulation, April 22, 2008; 117(16): 2071 - 2078.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
E. L. Hannan, M. Racz, G. Walford, D. R. Holmes, R. H. Jones, S. Sharma, S. Katz, and S. B. King III
Drug-Eluting Versus Bare-Metal Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 129 - 135.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. L. Hannan, C. Wu, G. Walford, A. T. Culliford, J. P. Gold, C. R. Smith, R. S.D. Higgins, R. E. Carlson, and R. H. Jones
Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease
N. Engl. J. Med., January 24, 2008; 358(4): 331 - 341.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
American College of Cardiology/American Heart Asso, 2007 Writing Group to Review New Evidence and Upda, S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, and D. O. Williams
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 172 - 209.
[Full Text] [PDF]

Home page
 CirculationHome page
S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, D. O. Williams, 2005 WRITING COMMITTEE MEMBERS, S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, et al.
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee
Circulation, January 15, 2008; 117(2): 261 - 295.
[Full Text] [PDF]

Home page
 Card Surg AdultHome page
J. M. Wilson and J. T. Willerson
Myocardial Revascularization with Percutaneous Devices
Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598.
[Full Text]

Home page
 HeartHome page
R. J Russo, P. D Silva, and M. Yeager
Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model
Heart, December 1, 2007; 93(12): 1609 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. D. Abbott, M. R. Voss, M. Nakamura, H. A. Cohen, F. Selzer, K. E. Kip, H. A. Vlachos, R. L. Wilensky, and D. O. Williams
Unrestricted Use of Drug-Eluting Stents Compared With Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood Institute Dynamic Registry
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2029 - 2036.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
E. Grube, K. D. Dawkins, G. Guagliumi, A. P. Banning, K. Zmudka, A. Colombo, L. Thuesen, K. Hauptman, J. Marco, W. Wijns, et al.
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions
Eur. Heart J., November 1, 2007; 28(21): 2578 - 2582.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. A. Simonton, B. Brodie, B. Cheek, F. Krainin, C. Metzger, J. Hermiller, S. Juk, P. Duffy, A. Humphrey, M. Nussbaum, et al.
Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting Stents: Results From a Large Prospective Multicenter Registry STENT Group
J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1214 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Machecourt, N. Danchin, J. M. Lablanche, J. M. Fauvel, J. L. Bonnet, S. Marliere, A. Foote, J. L. Quesada, H. Eltchaninoff, G. Vanzetto, et al.
Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients: The EVASTENT Matched-Cohort Registry
J. Am. Coll. Cardiol., August 7, 2007; 50(6): 501 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Jimenez-Quevedo, M. Sabate, D. J. Angiolillo, F. Alfonso, R. Hernandez-Antolin, M. SanMartin, J. A. Gomez-Hospital, C. Banuelos, J. Escaned, R. Moreno, et al.
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial
Eur. Heart J., August 2, 2007; 28(16): 1946 - 1952.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
C. Bode and M. Zehender
The use of antiplatelet agents following percutaneous coronary intervention: focus on late stent thrombosis
Eur. Heart J. Suppl., August 1, 2007; 9(suppl_D): D10 - D19.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. J.W. Wallitt, M. Jevon, and P. I. Hornick
Therapeutics of Vein Graft Intimal Hyperplasia: 100 Years On
Ann. Thorac. Surg., July 1, 2007; 84(1): 317 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Koide, M. Okazaki, M. Tamura, K. Ozumi, H. Takatsu, F. Kamezaki, A. Tanimoto, H. Tasaki, Y. Sasaguri, Y. Nakashima, et al.
PTEN reduces cuff-induced neointima formation and proinflammatory cytokines
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2824 - H2831.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H. M.M. van Beusekom, F. Saia, J. D. Zindler, P. A. Lemos, S. L. S.-t. Hoor, M. A.H. van Leeuwen, P. J. de Feijter, P. W. Serruys, and W. J. van der Giessen
Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus
Eur. Heart J., April 12, 2007; (2007) ehm064v1.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. Mauri, W.-h. Hsieh, J. M. Massaro, K. K.L. Ho, R. D'Agostino, and D. E. Cutlip
Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
N. Engl. J. Med., March 8, 2007; 356(10): 1020 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. J. Kereiakes
Does Clopidogrel Each Day Keep Stent Thrombosis Away?
JAMA, January 10, 2007; 297(2): 209 - 211.
[Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
A. R. Dalal, S. D'Souza, and M. S. Shulman
Brief review: Coronary drug-eluting stents and anesthesia: [Article de synthese court : Les tuteurs coronariens actifs et l'anesthesie]
Can J Anesth, December 1, 2006; 53(12): 1230 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. Rixe, S. Achenbach, D. Ropers, U. Baum, A. Kuettner, U. Ropers, W. Bautz, W. G. Daniel, and K. Anders
Assessment of coronary artery stent restenosis by 64-slice multi-detector computed tomography
Eur. Heart J., November 1, 2006; 27(21): 2567 - 2572.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. Ohtani, K. Egashira, Y. Ihara, K. Nakano, K. Funakoshi, G. Zhao, M. Sata, and K. Sunagawa
Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells
Hypertension, October 1, 2006; 48(4): 664 - 670.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S J Hong, M H Kim, T H Ahn, Y K Ahn, J H Bae, W J Shim, Y M Ro, and D-S Lim
Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes
Heart, August 1, 2006; 92(8): 1119 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. J. Kereiakes, H. Wang, J. J. Popma, R. E. Kuntz, D. J. Donohoe, J. Schofer, E. Schampaert, B. Meier, M. B. Leon, and J. W. Moses
Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents: Pooled Analysis of Five Clinical Trials
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 21 - 31.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. Tung, S. Kaul, G. A. Diamond, and P. K. Shah
Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.
Ann Intern Med, June 20, 2006; 144(12): 913 - 919.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. W. Moses, G. W. Stone, E. Nikolsky, G. S. Mintz, G. Dangas, E. Grube, S. G. Ellis, A. J. Lansky, G. Weisz, M. Fahy, et al.
Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials
J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2164 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C Roiron, P Sanchez, A Bouzamondo, P Lechat, and G Montalescot
Drug eluting stents: an updated meta-analysis of randomised controlled trials
Heart, May 1, 2006; 92(5): 641 - 649.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Weisz, M. B. Leon, D. R. Holmes Jr, D. J. Kereiakes, M. R. Clark, B. M. Cohen, S. G. Ellis, P. Coleman, C. Hill, C. Shi, et al.
Two-Year Outcomes After Sirolimus-Eluting Stent Implantation: Results From the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) Trial
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1350 - 1355.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. R. Holmes Jr, P. Teirstein, L. Satler, M. Sketch, J. O'Malley, J. J. Popma, R. E. Kuntz, P. J. Fitzgerald, H. Wang, E. Caramanica, et al.
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The SISR Randomized Trial
JAMA, March 15, 2006; 295(11): 1264 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 216 - 235.
[Full Text] [PDF]

Home page
 CirculationHome page
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
Circulation, January 3, 2006; 113(1): 156 - 175.
[Full Text] [PDF]

Home page
 HeartHome page
M Thomas
Are drug eluting stents really worth the money?
Heart, January 1, 2006; 92(1): 5 - 7.
[Full Text] [PDF]

Home page
 HeartHome page
A Bagust, A D Grayson, N D Palmer, R A Perry, and T Walley
Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study
Heart, January 1, 2006; 92(1): 68 - 74.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. Abou-Chebl, Q. Bashir, and J. S. Yadav
Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-up
Stroke, December 1, 2005; 36(12): e165 - e168.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Mauri, E. J. Orav, S. C. Candia, D. E. Cutlip, and R. E. Kuntz
Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials
Circulation, November 1, 2005; 112(18): 2833 - 2839.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. B. King III, G. Dangas, J. W. Moses, S. B. King III, G. Dangas, and J. W. Moses
Surgery Is Preferred for the Diabetic With Multivessel Disease
Circulation, September 6, 2005; 112(10): 1500 - 1515.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Togni, S. Windecker, R. Cocchia, P. Wenaweser, S. Cook, M. Billinger, B. Meier, and O. M. Hess
Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 231 - 236.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Serry and W. F. Penny
Endothelial Dysfunction After Sirolimus-Eluting Stent Placement
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 237 - 238.
[Full Text] [PDF]

Home page
 CirculationHome page
A. V. Finn, F. D. Kolodgie, J. Harnek, L.J. Guerrero, E. Acampado, K. Tefera, K. Skorija, D. K. Weber, H. K. Gold, and R. Virmani
Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents
Circulation, July 12, 2005; 112(2): 270 - 278.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. Balakrishnan, A. R. Tzafriri, P. Seifert, A. Groothuis, C. Rogers, and E. R. Edelman
Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents
Circulation, June 7, 2005; 111(22): 2958 - 2965.
[Abstract] [Full Text] [PDF]

Home page
 PERSPECT VASC SURG ENDOVASC THERHome page
B. H. Tonnessen and S. R. Money
Coronary Artery Revascularization Before Elective Major Vascular Surgery
Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2005; 17(2): 182-1 - 183.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
W. W. O'Neill, S. R. Dixon, and C. L. Grines
The year in interventional cardiology
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1117 - 1134.
[Full Text] [PDF]

Home page
 CirculationHome page
C.-W. Hwang, A. D. Levin, M. Jonas, P. H. Li, and E. R. Edelman
Thrombosis Modulates Arterial Drug Distribution for Drug-Eluting Stents
Circulation, April 5, 2005; 111(13): 1619 - 1626.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. D. Flaherty and C. J. Davidson
Diabetes and Coronary Revascularization
JAMA, March 23, 2005; 293(12): 1501 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
W. K. Laskey
Late Follow-Up From RAVEL: Transition From Intention to Observation
Circulation, March 1, 2005; 111(8): 958 - 960.
[Full Text] [PDF]

Home page
 CirculationHome page
A. J. Lansky, J. S. Hochman, P. A. Ward, G. S. Mintz, R. Fabunmi, P. B. Berger, G. New, C. L. Grines, C. G. Pietras, M. J. Kern, et al.
Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women: A Statement for Healthcare Professionals From the American Heart Association
Circulation, February 22, 2005; 111(7): 940 - 953.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Griffiths, A. Bakhai, D. West, M. Petrou, T. De Souza, N. Moat, J. Pepper, and C. Di Mario
Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease
Eur. J. Cardiothorac. Surg., September 1, 2004; 26(3): 528 - 534.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. R. Holmes Jr
How Many Grails Do We Need?
Circulation, May 11, 2004; 109(18): 2158 - 2159.
[Full Text] [PDF]

Home page
 CirculationHome page
P. S. Teirstein
A Chicken in Every Pot and a Drug-Eluting Stent in Every Lesion
Circulation, April 27, 2004; 109(16): 1906 - 1910.
[Full Text] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.